Adaptive Biotechnologies Corporation · NASDAQ:ADPT
Lo Francis sold 115,406 Adaptive Biotechnologies Corporation shares (Form 4)
Traded Sep 16, 2026 · Filed Sep 18, 2026
On Sep 16, 2026, Lo Francis (Chief People Officer) sold 115,406 Adaptive Biotechnologies Corporation shares at an average US$28.06 for US$3.24M under a trading plan, leaving 220,867 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 115,406 shares
- Price
- US$28.06 average (US$28.02 to US$28.57)
- Value
- US$3.24M
- Holding after
- 220,867 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief People Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Common Stock | Option exercise | 53,091 | US$12.14 | 283,804 | Direct |
| Sep 16, 2026 | Common Stock | Option exercise | 13,398 | US$8.46 | 297,202 | Direct |
| Sep 16, 2026 | Common Stock | Option exercise | 15,629 | US$3.99 | 312,831 | Direct |
| Sep 16, 2026 | Common Stock | Option exercise | 23,442 | US$8.12 | 336,273 | Direct |
| Sep 16, 2026 | Common Stock | Sale | 107,537 | US$28.02 | 228,736 | Direct |
| Sep 16, 2026 | Common Stock | Sale | 7,869 | US$28.57 | 220,867 | Direct |
Source
Related
- Adaptive Biotechnologies Corporation
- Lo Francis
- Adaptive Biotechnologies Corporation shareholders
- Form 4 · Lo Francis · Oct 5, 2026
- Form 4 · Lo Francis · Jul 17, 2026
- Form 4 · Lo Francis · Jul 6, 2026
- Form 4 · Lo Francis · Jun 8, 2026
- Form 4 · Lo Francis · Apr 10, 2026
- Form 4 · Rubinstein Julie · Oct 16, 2026
- Form 4 · Rubinstein Julie · Oct 13, 2026
- Form 4 · Rubinstein Julie · Oct 8, 2026
- Form 4 · Bobulsky Susan · Oct 8, 2026
- Form 4 · Rubinstein Julie · Oct 5, 2026